SCHEMBL15097379

SCHEMBL15097379

N#COc1ccc(N(CCCl)CCCl)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 5/20 0.38
ERBB2 P04626 5/20 0.38
ALDH1A1 P00352 3/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
HIF1A Q16665 3/20 0.38
LMNA P02545 3/20 0.38
MAPT P10636 2/20 0.38
NFKB1 P19838 2/20 0.38
THPO P40225 2/20 0.38
PMP22 Q01453 2/20 0.38
GMNN O75496 1/20 0.38
CYP2D6 P10635 1/20 0.38
GABRA1 P14867 1/20 0.38
TSHR P16473 1/20 0.38
GABRA2 P47869 1/20 0.38
GABRB2 P47870 1/20 0.38
SLCO1B3 Q9NPD5 1/20 0.38
CYP3A4 P08684 3/20 0.37
ALOX15 P16050 2/20 0.37
KMT2A Q03164 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL659196 0.75 CA12 (0.46) EGFRERBB2ALDH1A1SMN1; SMN2HIF1A
SCHEMBL18530726 0.75 ALDH1A1 (0.41) EGFRERBB2ALDH1A1SMN1; SMN2HIF1A
SCHEMBL24787 0.72 CA1 (0.32) ALDH1A1MAPTNFKB1PMP22TSHR
SCHEMBL6744975 0.71 EGFR (0.44) EGFRERBB2ALDH1A1SMN1; SMN2HIF1A
SCHEMBL13545738 0.70 EGFR (0.41) EGFRERBB2ALDH1A1SMN1; SMN2HIF1A
SCHEMBL8430455 0.70 EGFR (0.41) EGFRERBB2ALDH1A1SMN1; SMN2HIF1A
SCHEMBL14619522 0.70 EGFR (0.41) EGFRERBB2ALDH1A1SMN1; SMN2HIF1A
SCHEMBL8985411 0.70 ALDH1A1 (0.33) EGFRALDH1A1MAPTTSHRALOX15
SCHEMBL8508241 0.69 EGFR (0.47) EGFRERBB2ALDH1A1SMN1; SMN2HIF1A
SCHEMBL12421704 0.69 EGFR (0.53) EGFRERBB2ALDH1A1SMN1; SMN2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9193687-B2 Phenyl N-mustard linked to DNA-affinic molecules or water-soluble aryl rings, method and their use as cancer therapeutic agents ACADEMIA SINICA (TW) 2015-11-24 US disclosed
US-20130178494-A1 PHENYL N-MUSTARD LINKED TO DNA-AFFINIC MOLECULES OR WATER-SOLUBLE ARYL RINGS, METHOD AND THEIR USE AS CANCER THERAPEUTIC AGENTS ACADEMIA SINICA (TW) 2013-07-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130178494-A1 PHENYL N-MUSTARD LINKED TO DNA-AFFINIC MOLECULES OR WATER-SOLUBLE ARYL RINGS, METHOD AND THEIR USE AS CANCER THERAPEUTIC AGENTS PCNA, WEE1, UNG EGFR 543/4885ERBB2 424/4885ALDH1A1 1712/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.